• otv

Tag: Bharat Biotech

 Covaxin
Review Process Begins For WHO Listing Of Covaxin: Bharat Biotech

The Hyderabad-based company had said in May that that application for EUL was submitted to WHO-Geneva and regulatory approvals are expected by July-September 2021.

No Data To Show Children Will Be Seriously Hit In Next COVID Waves: AIIMS chief
Serum Institute To Conduct Clinical Trials Of Novavax For Children

Novavax Inc had announced that NVX-CoV2373, its recombinant nanoparticle protein-based Covid-19 vaccine, demonstrated 100 per cent protection against moderate and severe disease, 90.4 per cent efficacy overall.

Covaxin Effective For 9-12 Months, No Serious Side-Effects So Far: AIIMS
Bharat Biotech Supplies Covaxin To 16 States

Bharat Biotech dispatched its Covid-19 vaccine Covaxin to nine states through the government of India and to 16 states through the respective state governments.

Covaxins Phase-3 Trials Begin: Bharat Biotech
Working For Full US FDA Approval Of Covaxin: Bharat Biotech

The FDA had on Thursday recommended Ocugen, the US partner of the Indian vaccine maker, to "pursue a Biologics Licence Application (BLA) submission instead of an EUA application" and "requested additional information and data".

Covaxin
Bharat Biotech Supplying Covaxin To 18 States Including Odisha

Bharat Biotech has been directly supplying its Covid-19 vaccine Covaxin to 18 states since May 1

COVAXIN
COVID-19 Fight: Bharat Biotech Begins Covaxin Supplies To 14 States

Bharat Biotech has started direct supplies of its Covid-19 vaccine Covaxin to 14 states.

Covaxin Price Slashed To Rs 400/Dose For States
Covaxin Price Slashed To Rs 400/Dose For States

Bhubaneswar: A day after Serum Institute of India reduced Covishield vaccine price for States to Rs 300 per dose as a philanthropic gesture, Bharat Biotech also slashed the price of…

COVID19 Vaccine: Covaxin Price Fixed At Rs 600 For States, Rs 1,200 For Pvt Hospitals
COVID19 Vaccine: Covaxin Price Fixed At Rs 600 For States, Rs 1,200 For Pvt Hospitals

New Delhi: Bharat Biotech on Saturday said it would provide its COVID-19 vaccine, Covaxin, to state governments at Rs 600 per dosage. The Hyderabad-based vaccine major also said that it would…

Coronavirus
Faster Jabs, Surveillance Can Only Tame Triple-Mutant Indian Virus

New Delhi: Increasing efforts towards faster mass vaccination and virus surveillance is the key to ward off dangers posed by a triple-mutant coronavirus now present in the country, health experts…

Vaccine
Govt To Provide Rs 4,500 Cr Booster To Vaccine Manufacturers For Ramping Up Capacity

New Delhi: Looking to ramp up supplies ahead of the opening of Covid-19 vaccination to all citizens over 18 years of age, the government has approved a payment of about…

United States
Only 311 Of 1.9 Mn Covaxin Beneficiaries Reported Side Effects: Govt

New Delhi: Bharat Biotech’s Covaxin has a negligible number of side effects reported among the beneficiaries of the Covid-19 vaccine, NITI Aayog’s Member (Health), VK Paul said on Thursday. “The vaccine has been administered so far to 19 lakh people and only 311 individuals of them have reported minimal side effects. “It has stood the […]

Bharat Biotech
Covaxin Demonstrates Interim Clinical Efficacy Of 81%

Hyderabad: Bharat Biotech on Wednesday announced the first interim analysis of Covaxin, which shows the efficacy of the Covid-19 vaccine to be at 81 per cent. The Hyderabad-based vaccine maker said whole virion inactivated Covid-19 vaccine candidate demonstrated an interim vaccine efficacy of 81 per cent in its Phase 3 clinical trial. The trials involved […]

vaccines
Covaxin, Covishield New Fact-Sheets: Know Who Can’t Take Vaccines, the Side-effects

Bhubaneswar: With the ‘vaccine hesitancy’ getting manifested in nearly half a dozen districts– including the Capital City– in the State despite a mere 0.01 per cent showing any AEFI (adverse events following immunisation) signs, the two vaccine manufacturers – Bharat Biotech and Serum Institute India – have released fact-sheets that tell who are eligible for […]

55L Covaxin Procured For Rs 206 Per Dose, 1.1 Cr Covidshield Vaccines For Rs 200 A Piece
55L Covaxin Procured For Rs 206 Per Dose, 1.1 Cr Covidshield Vaccines For Rs 200 A Piece

New Delhi: Days before the commencement of the nationwide Covid-19 vaccination drive, the Union Health Ministry said on Tuesday that 1.1 crore Covishield and 55 lakh Covaxin vaccines have been procured at a cost of Rs 200 and Rs 206 per dose, respectively. However, BBIL will provide 16.5 lakh doses of Covaxin free of cost […]

Serum Institute, Bharat Biotech Pledge For Smooth Rollout Of COVID-19 Vaccines
Serum Institute, Bharat Biotech Pledge For Smooth Rollout Of COVID-19 Vaccines

New Delhi: Vaccine makers Serum Institute of India and Bharat Biotech on Tuesday said both the companies jointly pledge for smooth roll out of COVID-19 vaccines in the country and the world. In a show of solidarity after some bitter comments, Adar Poonawala and Krishna Ella, jointly on behalf of Serum Institute and Bharat Biotech, […]

COVID-19 Vaccine: Bharat Biotech Dispatches 1st Batch Of Covaxin For Immunisation Drive
COVID-19 Vaccine: Bharat Biotech Dispatches 1st Batch Of Covaxin For Immunisation Drive

New Delhi: Hyderabad-based Bharat Biotech has sent the first batch of its Covid vaccine, Covaxin, to the government for further distribution as the immunisation drive in the country is set to start in coming days, its CMD Dr Krishna Ella said on Monday. “We have already sent the batch to the Central Research Institute in […]

COVAXIN
AIDAN Asks DCGI To Withdraw Approval For Bharat Biotech's Covid-19 Vaccine

New Delhi: The All India Drug Action Network (AIDAN) said it is shocked to learn of the SEC’s recommendation to grant REU approval to Bharat Biotech’s COVAXIN in “clinical trial mode” and “specially in the context of infection by mutant strains”. “In light of the intense concerns arising from the absence of efficacy data and […]

Expert Panel Recommends Bharat Biotech's 'Covaxin' For Emergency Use
Expert Panel Recommends Bharat Biotech's 'Covaxin' For Emergency Use

New Delhi: The Subject Expert Committee of Central Drug Standard Control Organization on Saturday recommended Bharat Biotech’s ‘Covaxin’ for emergency use in India. However, the final decision on its approval will be taken by the Drug Controller General of India (DCGI). Expert panel recommends granting permission for restricted emergency use authorization for Bharat Biotech’s indigenously […]

Bharat Biotech Calls Out For Participating In Covaxin Phase 3 Trials To Ensure Protection Against Covid-19
Bharat Biotech Calls Out For Participating In Covaxin Phase 3 Trials To Ensure Protection Against Covid-19

New Delhi: Bharat Biotech has said that it will be advisable to participate in the Phase 3 efficacy trial for its indigenous Covaxin and get vaccinated to ensure protection against Covid-19 as it may take months for people above 50 years to get the vaccine. In frequently asked questions (FAQ) on its vaccine trials, Bharat […]

Covaxin
Bharat Biotech Recruits 13K Volunteers For Covaxin Phase III Trials

Hyderabad: Bharat Biotech on Tuesday announced successful recruitment of 13,000 volunteers, and continued progress towards achieving the goal of 26,000 participants for Phase III clinical trial of its coronavirus vaccine Covaxin across multiple sites in India. The Phase III human clinical trials of Covaxin began mid-November, targeted to be done in 26,000 volunteers across India. […]

COVAXIN
Inactivated Vaccines Are Safest With Lesser Adverse Reactions: Bharat Biotech

New Delhi: Bharat Biotech has claimed that amongst all the vaccine platforms such as an mRNA-based vaccine, DNA-based vaccine, vector-based vaccine, or live attenuated vaccines, etc., the inactivated vaccines being developed by it for Covid 19 are safest, and hence, the adverse reactions are lesser. In a series of frequently asked questions (FAQs) for its […]

Envoys Of 64 Countries Visit COVID-19 Vaccine Makers In Hyderabad
Envoys Of 64 Countries Visit COVID-19 Vaccine Makers In Hyderabad

Hyderabad: Envoys of 64 countries on Wednesday visited the facilities of Bharat Biotech and Biological E, which are developing vaccines for coronavirus. After landing in Hyderabad by a special Air India flight, the Ambassadors and High Commissioners from the countries in Asia, Africa, Europe, North America, South America, and Oceania reached Genome Valley on the […]

COVID Vaccine: Bharat Biotech Seeks Emergency Use Nod For Covaxin
COVID Vaccine: Bharat Biotech Seeks Emergency Use Nod For Covaxin

New Delhi: Hyderabad-based Bharat Biotech on Monday filed an application with the Drugs Controller General of India (DCGI) for emergency use authorisation of its Covid-19 vaccine- Covaxin. The application was filed before the apex drug regulator on Monday evening, a company source told IANS on the condition of anonymity. Covaxin, India’s indigenous Covid-19 vaccine by […]

COVID-19 Vaccines
Singapore To Contribute $5Mn To Help Other Countries Get COVID-19 Vaccines

Singapore: Singapore announced to contribute $5 million on Friday to support low- and lower-middle-income countries procure Covid-19 vaccines. The announcement was made in a joint statement by the Ministries of Foreign Affairs and Health, reports Xinhua news agency. The money would go through the Covid-19 Vaccine Global Access (COVAX) Advance Market Commitment (AMC) mechanism, which […]

Indian Health Experts Hail mRNA Vaccine For Covid Treatment
Covid-19 Vaccination In Odisha: Chief Minister Announces Priority Groups

Bhubaneswar: Chief Minister Naveen Patnaik on Wednesday announced that people above 60 years, pregnant women and health workers will be given priority during the vaccination process for Covid-19 once the vaccine is available. He made the announcement while reviewing the Coronavirus scenario in the State. The Odisha government had already commenced process for the preparation […]